What's new

Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts

Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts

Apr 10, 2025 - 12:16
 0
Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts
Read More

Tags:

Previous Article

Polestar Q1 retail sales grew by 76% compared to the same quarter last year

Next Article

Genius Foods suffers £3.7 million loss

Related Posts

Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, Date of authorisation: 20/04/2007, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Methylphenidate product-specific bioequivelance guidance

Methylphenidate product-specific bioequivelance guidance

Mar 17, 2025  0

Human medicines European public assessment report (EPAR): Bortezomib Fresenius Kabi, bortezomib, Date of authorisation: 14/11/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0